Mucinex Fast-max Tablet, Coated
NDC Package 72854-157-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mucinex Fast-max (dextromethorphan hydrobromide, guaifenesin) tablets is do not take more than 12 caplets in any 24-hour periodadults and children 12 years of age and over: take 2 caplets every 4 hourschildren under 12 years of age: do not use. This formulation utilizes a tablet, coated delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 72854-157 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
72854-157-20
Package Description
2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK
Product Code
72854-157
11-Digit Billing Format
72854015720
RxNorm Crosswalk
  • RxCUI: 2173726 - dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Tablet
  • RxCUI: 2173726 - dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Mucinex Fast-max Severe Congestion And Cough
Non-Proprietary Name
Dextromethorphan Hydrobromide, Guaifenesin
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not take more than 12 caplets in any 24-hour periodadults and children 12 years of age and over: take 2 caplets every 4 hourschildren under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Reckitt Benckiser Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72854-157-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet, coated in 1 blister pack of Mucinex Fast-max Severe Congestion And Cough, a human over the counter drug labeled by Reckitt Benckiser Llc. This tablet, coated is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on July 01, 2025. The current certification is valid through December 31, 2027.

How is this Reckitt Benckiser Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72854015720. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72854-157-20
11-Digit CMS (5-4-2)
72854-0157-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.